CRP levels – Page 2 – Communicable Diseases Research

Clinical features, management, and outcome of hemodialysis patients with SARS-CoV-2

SARS-CoV-2 혈액투석 환자의 임상 양상, 관리 및 결과

Article

Published on 2022-02-012022-09-11
Journal: Therapeutic apheresis and dialysis : official peer [Category] COVID19(2023년), SARS, 바이오마커,

Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)—study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial

ARDS 및 COVID-19 환자에서 덱사메타손의 효과(REMED 시험) - 전향적, 다기관, 공개 라벨, 병렬 그룹, 무작위 대조 시험을 위한 연구 프로토콜

Update

Published on 2022-01-152022-09-10
Journal: Trials [Category] SARS, 임상,

[키워드] 1:1 Administered Adult patients adverse event adverse events age ARDS ARMS Barthel Index Charlson Comorbidity Index clinical Comorbidity conducted consequence Corticosteroid Corticosteroids COVID-19 COVID-19 pneumonia CRP level CRP levels Czech Republic deleterious effect Dexamethasone dexamethasone 6 mg different dose dose doses of corticosteroids Effect Efficacy and safety enrolled EudraCT Factor followed by ICUs Independence Inflammatory intensive care unit intensive care units intravenously life marker mechanical ventilation moderate to severe Mortality once daily Open-label outcome oxygen Oxygen therapy parallel-group participant patients with ARDS patients with COVID-19 patients with moderate per day Pneumonia Prevent primary endpoint protocol Quality of life randomisation randomised randomised controlled trial randomization Randomized controlled trial SARS-CoV-2 virus scale secondary endpoint Secondary endpoints severe ARDS Stratification therapeutic potential Treatment Trial Trial registration university hospital ventilator-free day Ventilator-free days WHO
[DOI] 10.1186/s13063-021-05963-6 PMC 바로가기 [Article Type] Update

Efficacy and Safety of “Three Chinese Patent Medicines and Three TCM Prescriptions” for COVID-19: A Systematic Review and Network Meta-Analysis

Review Article

Published on 2022-01-122022-10-31
Journal: Evidence-based Complementary and Alternative Medicine : eCAM [Category] COVID-19,

Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection

항 -SARS-COV-2 항체 수준 및 백신 반응의 동역학 : SARS-COV-2 감염으로부터 회복 후 해결되지 않은 염증의 잠재적 역할

Article

Published on 2022-01-102022-09-01
Journal: Scientific Reports [Category] 바이오마커, 유전자 메커니즘, 진단,

[키워드] administration anti-SARS-CoV-2 IgG antibody appear baseline best Biomarker BMI BNT162b2 BNT162b2 vaccine characterized circulating Cohort conditions CRP CRP level CRP levels Epidemiology Factors growth healthcare worker identify IgG level IgG levels immune response immunization Inflammation Inflammatory diseases Inter-individual variation kinetic Kinetics MCHC naïve subjects neutrophil neutrophil count pattern persistence positive Post-infection Post-vaccine Predictive markers Risk factors RNA vaccines SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine second dose subject subjects vaccination Vaccine viral infection with COVID-19
[DOI] 10.1038/s41598-021-04344-y PMC 바로가기 [Article Type] Article

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh

COVID-19 감염의 중증도가 다른 환자의 질병 특성 및 혈청 반응: 방글라데시 다카의 종단 코호트 연구

Research Article

Published on 2022-01-042022-09-12
Journal: PLoS Neglected Tropical Diseases [Category] 진단,

[키워드] addition age age and sex analyzed antibody Antibody Response antibody response against Antibody responses Asymptomatic asymptomatic infection asymptomatic infections biochemical caused Characteristics clinician co-morbid condition co-morbid conditions Community conducted Control COVID-19 COVID-19 disease COVID-19 illness COVID-19 infection CRP CRP level CRP levels D-dimer disease disease severity Disease spectrum elevated enrolled Enrollment evaluate exclusion criteria ferritin ferritin level ferritin levels Follow-up visit follow-up visits Gender geographical region healthy healthy controls help hematological parameter hematological parameters hospital IgG antibodies IgG antibody IgG levels IgM and IgG immunological parameter immunological parameters infected individual Infection levels of antibody longitudinal cohort study longitudinal study lymphocyte lymphocyte counts male many cases Mild Mild disease moderate neutrophil neutrophil count NLR normal range Older age onset of symptom outcome outcomes participant Patient patients patients with COVID-19 predict progression RBD Receptor binding domain responsible risk factor Risk factors SARS-CoV-2 serological response seropositive Severe case severe cases severe COVID-19 disease severe COVID-19 illness severe disease severe disease manifestation severe patients severity of COVID-19 significantly higher Spike protein spike protein of SARS-CoV-2 the disease the spike protein Viral load
[DOI] 10.1371/journal.pntd.0010102 PMC 바로가기 [Article Type] Research Article

Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19

Observational Study

Published on 2022-01-012022-10-05
Journal: European Journal of Clinical Investigation [Category] 임상, 치료기술,

[키워드] age all-cause mortality C-reactive protein (CRP Cancer Cardiac complications cardiac troponin Chronic kidney disease CKD Clinical characteristics coronary disease COVID-19 CRP levels defined diagnosed disease highlighting Hospitalization hospitalized patient hypertension identify Inflammation Injury IQR Italian Italian study males median median age multicentre multivariable analysis Myocardial myocardial injury Occurrence outcome Patient patients hospitalized patients with SARS-CoV-2 predictor Prevalence primary end-point prognostic proportion protective factor Retrospective study San Raffaele Hospital SARS-coronavirus-2 SARS-CoV-2 systemic inflammation troponin troponin level troponin levels with COVID-19
[DOI] 10.1111/eci.13703 PMC 바로가기 [Article Type] Observational Study

Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir

렘데시비르 치료를 받은 코로나19 환자의 염증 지표 상승은 나쁜 결과와 관련이 있습니다.

Observational Study

Published on 2022-01-012022-09-11
Journal: Journal of medical virology [Category] SARS, 바이오마커, 임상, 치료제,

[키워드] administration analyzed Antiviral C-reactive protein center clinical outcomes coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient CRP CRP level CRP levels D-dimer death decrease Hospital stay identify Inflammatory Inflammatory marker inflammatory markers Inflammatory response intubation knowledge Lactate lactate dehydrogenase modify outcome oxygen Patient patients patients hospitalized performed Prognostic factor progressed remained Remdesivir requiring supplemental oxygen retrospective cohort study shown significantly significantly higher study period supplemental oxygen Support treated treatment strategy
[DOI] 10.1002/jmv.27280 PMC 바로가기 [Article Type] Observational Study

Early Fall in C-Reactive Protein (CRP) Level Predicts Response to Tocilizumab in Rapidly Progressing COVID-19: Experience in a Single-Arm Pakistani Center

Internal Medicine

Published on 2021-11-302022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] 48 hour A significant reduction Adequate age all-cause mortality baseline being category center Clinical data Clinical improvement confirmed COVID-19 case coronavirus disease COVID-19 COVID-19 disease COVID-19 treatment CRP CRP levels demonstrated disease dose Efficacy experience female ferritin level healthcare hospital identify in-hospital mortality inflammatory biomarkers intravenous tocilizumab Level magnitude majority objective outcome Oxygen requirement Oxygenation parameter Patient patients predict Primary outcome Protein receiving response Result secondary outcome Seven significantly increased survival outcome covid-19 the mean the patient Tocilizumab tocilizumab administration Treatment were recorded
[DOI] 10.7759/cureus.20031 PMC 바로가기 [Article Type] Internal Medicine

Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study

바이오 마커의 사용 및 오용 및 COVID-19의 관리에서 D- 차이 및 C- 반응성 단백질의 역할 : 전향 적 코호트 연구의 사후 분석

Original Article

Published on 2021-11-242022-08-31
Journal: Clinics [Category] MERS, SARS, 바이오마커,

[키워드] acute respiratory syndrome adjusted Admission age Analysis assessment association associations Biomarker Biomarkers C-reactive protein C-reactive protein (CRP Cohort studies Comorbidities Complication coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 CRP CRP level CRP levels D-dimer D-dimer level death demonstrated electronic patient record Electronic patient records elevated evaluate failure FEU fibrinogen Health Care Costs high mortality hospital hospital cost Hospital mortality hospitalized patient hospitalized patients incidence indication Infection Inflammatory Inpatient Inpatients Laboratory lead logistic regression model management Mortality number of comorbidities Occurrence Odds ratio patient records post-hoc analysis predicted Prognosis prospective cohort study respiratory sequential organ failure assessment score severe acute respiratory syndrome Coronavirus Sex statistically significant systemic inflammatory thrombotic Trigger Venous Thromboembolism VTE were used with COVID-19
[DOI] 10.6061/clinics/2021/e3547 PMC 바로가기 [Article Type] Original Article

Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases

중증 COVID-19 사례에서 혈장교환 요법을 사용한 임상 결과, 실험실 소견 및 염증성 사이토카인 수치 개선

Article

Published on 2021-11-012022-09-11
Journal: Respiratory medicine [Category] 바이오마커, 임상,

[키워드] Blood oxygen saturation clinical clinical and laboratory parameters Clinical outcome clinical symptom Clinical symptoms consequence control group correlated cough courses COVID-19 COVID-19 patient CRP levels cytokine Cytokine storm Cytokines disease enrolled evaluated excessive immune response Fever form IFN-γ IL-1 IL-17 IL-6 IMPROVE improvement Inflammation Inflammatory cytokine Inflammatory cytokines inflammatory markers investigated Laboratory laboratory parameter Laboratory parameters oxygen Patient Plasmapheresis protocol receiving reduce Serum level serum levels Severe case severe COVID-19 severe COVID-19 patients severe forms of COVID-19 significant decrease significantly standard treatment suggested the disease therapeutic effect therapy time interval weakness
[DOI] 10.1016/j.rmed.2021.106669 PMC 바로가기 [Article Type] Article